We are live on ! Find out more
FC

Fayerweather Charles Portfolio holdings

AUM $57.2M
1-Year Est. Return 11.87%
This Fund
S&P 500
This Quarter Est. Return
+3.42%
1 Year Est. Return
+11.87%
3 Year Est. Return
+47.45%
5 Year Est. Return
+76.34%
10 Year Est. Return
AUM
$71M
AUM Growth
+$10.5M
Cap. Flow
+$8.42M
Cap. Flow %
11.86%
Top 10 Hldgs %
41.01%
Holding
70
New
6
Increased
46
Reduced
8
Closed
1

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$428K
2
CB icon
Chubb
CB
+$405K
3
FISV
Fiserv Inc
FISV
+$402K
4
DHR icon
Danaher
DHR
+$386K
5
ATR icon
AptarGroup
ATR
+$378K

Sector Composition

Rank Sector Weight
1 Healthcare 25.42%
2 Technology 19.97%
3 Industrials 17.41%
4 Consumer Staples 10.48%
5 Financials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
51
Pfizer
PFE
$143B
$360K 0.51%
12,827
MRK icon
52
Merck
MRK
$322B
$359K 0.51%
7,126
CTSH icon
53
Cognizant
CTSH
$26.5B
$351K 0.49%
5,600
IPGP icon
54
IPG Photonics
IPGP
$3.4B
$348K 0.49%
3,620
-40
-1% -$3.39K
DE icon
55
Deere & Co
DE
$165B
$328K 0.46%
4,260
+200
+5% +$15.7K
ECL icon
56
Ecolab
ECL
$79.8B
$312K 0.44%
2,795
+520
+23% +$55.2K
IBM icon
57
IBM
IBM
$213B
$307K 0.43%
+2,116
New +$270K
NXPI icon
58
NXP Semiconductors
NXPI
$60.8B
$288K 0.41%
3,560
+300
+9% +$22.4K
ZBH icon
59
Zimmer Biomet
ZBH
$18.8B
$282K 0.4%
2,722
-309
-10% -$29.9K
PX
60
DELISTED
Praxair Inc
PX
$257K 0.36%
2,245
-1,155
-34% -$121K
ALNY icon
61
Alnylam Pharmaceuticals
ALNY
$38.3B
$253K 0.36%
4,025
+670
+20% +$44.5K
XYL icon
62
Xylem
XYL
$28.5B
$249K 0.35%
+6,100
New +$225K
GOOG icon
63
Alphabet (Google) Class C
GOOG
$4.11T
$246K 0.35%
6,600
T icon
64
AT&T
T
$164B
$242K 0.34%
8,190
GWW icon
65
W.W. Grainger
GWW
$64.2B
$235K 0.33%
+1,010
New +$212K
APH icon
66
Amphenol
APH
$185B
$209K 0.29%
+14,480
New +$188K
BMY icon
67
Bristol-Myers Squibb
BMY
$129B
-3,050
Closed -$210K

Similar funds

Fayerweather Charles's Q1 2016 Portfolio in Review

As of Q1 2016, Fayerweather Charles held 70 positions worth $71M, up 17% from $60.5M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Fayerweather Charles deployed $8.42M of net new capital in Q1 2016, opening 6 new positions and adding to 46 existing holdings. Its largest new stake was Danaher: 6,478 shares worth $414K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Emerson Electric, an estimated $427K trimmed.

  • Fayerweather Charles's largest Q1 2016 buy was Danaher: 6,478 shares worth $414K.
  • Fayerweather Charles added most to CVS Health in Q1 2016, an estimated $428K increase.
  • Fayerweather Charles's biggest Q1 2016 reduction was Emerson Electric, cutting an estimated $427K.
  • Fayerweather Charles fully exited Bristol-Myers Squibb in Q1 2016, selling an estimated $210K.
  • Fayerweather Charles's ten largest holdings make up 41% of its $71M portfolio in Q1 2016.
  • Fayerweather Charles opened 6 new positions and closed 1 in Q1 2016.
  • Fayerweather Charles's portfolio value rose 17% quarter-over-quarter to $71M.

Based on Fayerweather Charles's 13F filing for Q1 2016, filed 27 May 2016.